CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
37.945
0.77%
Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.130
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.022046 %
Charges from full value of position ($-4.19)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.022046%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000176 %
Charges from full value of position ($-0.03)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000176%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 5%
Stock exchange Germany
Commission on trade 0%

*Information provided by Capital.com

Qiagen NV ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 37.655
Open* 37.655
1-Year Change* -20.38%
Day's Range* 37.425 - 37.945
52 wk Range 34.74-51.18
Average Volume (10 days) 1.07M
Average Volume (3 months) 27.05M
Market Cap 9.21B
P/E Ratio 27.98
Shares Outstanding 228.18M
Revenue 1.95B
EPS 1.44
Dividend (Yield %) N/A
Beta 0.42
Next Earnings Date Feb 5, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 1, 2023 37.945 0.510 1.36% 37.435 37.955 37.405
Nov 30, 2023 37.655 0.420 1.13% 37.235 37.705 37.235
Nov 29, 2023 37.575 0.450 1.21% 37.125 37.765 37.055
Nov 28, 2023 37.065 0.190 0.52% 36.875 37.215 36.755
Nov 27, 2023 37.155 0.080 0.22% 37.075 37.655 37.075
Nov 24, 2023 37.245 -0.120 -0.32% 37.365 37.605 37.125
Nov 23, 2023 37.465 0.120 0.32% 37.345 37.535 37.035
Nov 22, 2023 37.525 0.570 1.54% 36.955 37.595 36.915
Nov 21, 2023 36.865 0.785 2.18% 36.080 36.895 36.080
Nov 20, 2023 36.110 -0.010 -0.03% 36.120 36.485 36.020
Nov 17, 2023 36.110 0.035 0.10% 36.075 36.595 36.075
Nov 16, 2023 36.270 0.220 0.61% 36.050 36.425 36.050
Nov 15, 2023 36.455 0.170 0.47% 36.285 36.855 36.010
Nov 14, 2023 36.365 0.615 1.72% 35.750 36.685 35.750
Nov 13, 2023 35.790 0.380 1.07% 35.410 35.840 35.310
Nov 10, 2023 35.140 -0.260 -0.73% 35.400 35.690 35.020
Nov 9, 2023 35.910 -0.110 -0.31% 36.020 36.395 35.840
Nov 8, 2023 36.305 0.020 0.06% 36.285 36.695 36.285
Nov 7, 2023 36.485 0.575 1.60% 35.910 36.655 35.890
Nov 6, 2023 36.260 -0.165 -0.45% 36.425 36.595 36.210

Qiagen NV Events

Time (UTC) Country Event
Tuesday, December 12, 2023

Time (UTC)

13:00

Country

NL

Event

Qiagen NV at Exane BNPP Diagnostics, Imaging & Life Sciences CEO Conference (Virtual)
Qiagen NV at Exane BNPP Diagnostics, Imaging & Life Sciences CEO Conference (Virtual)

Forecast

-

Previous

-
Monday, February 5, 2024

Time (UTC)

21:05

Country

NL

Event

Q4 2023 Qiagen NV Earnings Release
Q4 2023 Qiagen NV Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 2141.52 2251.66 1870.35 1526.42 1501.85
Revenue 2141.52 2251.66 1870.35 1526.42 1501.85
Cost of Revenue, Total 756.955 800.837 637.631 521.162 499.271
Gross Profit 1384.56 1450.82 1232.71 1005.26 1002.58
Total Operating Expense 1610.06 1621.57 1483.92 1547.76 1235.27
Selling/General/Admin. Expenses, Total 603.945 584.468 525.362 505.268 508.146
Research & Development 189.859 189.964 149.072 157.448 161.852
Depreciation / Amortization 14.531 18.542 20.811 29.973 39.032
Unusual Expense (Income) 44.768 27.762 151.039 333.91 26.966
Operating Income 531.46 630.084 386.431 -21.337 266.581
Interest Income (Expense), Net Non-Operating -19.1 -5.122 -59.918 -43.696 -70.168
Other, Net 0.241 0.871 112.959 -12.743 29.324
Net Income Before Taxes 512.601 625.833 439.472 -77.776 225.737
Net Income After Taxes 423.211 512.599 359.188 -41.455 190.38
Minority Interest 0
Net Income Before Extra. Items 423.211 512.599 359.188 -41.455 190.38
Net Income 423.211 512.599 359.188 -41.455 190.38
Income Available to Common Excl. Extra. Items 423.211 512.599 359.188 -41.455 190.38
Income Available to Common Incl. Extra. Items 423.211 512.599 359.188 -41.455 190.38
Dilution Adjustment 0
Diluted Net Income 423.211 512.599 359.188 -41.455 190.38
Diluted Weighted Average Shares 230.136 232.034 234.214 226.777 233.456
Diluted EPS Excluding Extraordinary Items 1.83896 2.20915 1.53359 -0.1828 0.81549
Diluted Normalized EPS 1.99957 2.30715 2.00343 0.77427 0.9129
Total Extraordinary Items
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 494.857 485.398 497.984 499.631 515.512
Revenue 494.857 485.398 497.984 499.631 515.512
Cost of Revenue, Total 182.705 177.922 180.46 178.58 184.494
Gross Profit 312.152 307.476 317.524 321.051 331.018
Total Operating Expense 389.425 388.688 393.411 401.972 393.355
Selling/General/Admin. Expenses, Total 145.523 147.58 154.211 145.462 151.418
Research & Development 49.893 54.718 44.719 48.868 49.896
Depreciation / Amortization 2.702 2.657 5.969 2.846 2.799
Unusual Expense (Income) 8.602 5.811 8.052 26.216 4.748
Operating Income 105.432 96.71 104.573 97.659 122.157
Interest Income (Expense), Net Non-Operating -3.054 11.954 1.387 -2.452 -6.521
Other, Net -0.062 0.123 -0.123 0.511 -0.112
Net Income Before Taxes 102.316 108.787 105.837 95.718 115.524
Net Income After Taxes 80.786 85.035 88.844 82.394 96.661
Net Income Before Extra. Items 80.786 85.035 88.844 82.394 96.661
Net Income 80.786 85.035 88.844 82.394 96.661
Income Available to Common Excl. Extra. Items 80.786 85.035 88.844 82.394 96.661
Income Available to Common Incl. Extra. Items 80.786 85.035 88.844 82.394 96.661
Diluted Net Income 80.786 85.035 88.844 82.394 96.661
Diluted Weighted Average Shares 230.517 230.602 230.358 230.084 229.938
Diluted EPS Excluding Extraordinary Items 0.35046 0.36875 0.38568 0.3581 0.42038
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.37992 0.38845 0.41502 0.45618 0.43766
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 2393.95 2109.6 1624.41 1570.25 2155.06
Cash and Short Term Investments 1418.27 1065.3 715.233 753.233 1393.69
Cash 122.314 235.381 245.373 189.569 208.083
Short Term Investments 687.597 184.785 117.249 563.664 1185.6
Total Receivables, Net 434.068 469.663 486.605 484.608 422.091
Accounts Receivable - Trade, Net 333.518 376.213 389.058 385.117 351.612
Total Inventory 357.96 327.525 291.181 170.704 162.912
Prepaid Expenses 50.958 60.629 61.159 45.409 48.25
Other Current Assets, Total 132.7 186.484 70.227 116.294 128.122
Total Assets 6287.73 6146.95 5869.62 5235.62 5748.33
Property/Plant/Equipment, Total - Net 757.693 739.077 661.894 455.243 511.659
Property/Plant/Equipment, Total - Gross 1260.66 1371.49 1292.34 1154.37 1115.09
Accumulated Depreciation, Total -502.967 -632.416 -630.443 -699.13 -603.43
Goodwill, Net 2352.57 2350.76 2364.03 2140.5 2108.54
Intangibles, Net 544.796 627.436 726.194 632.434 475.043
Other Long Term Assets, Total 215.225 294.676 488.995 356.488 437.434
Total Current Liabilities 974.523 1517.47 572.175 951.345 972.189
Accounts Payable 98.734 101.224 118.153 84.767 69.415
Accrued Expenses 215.702 219.936 220.755 332.151 209.748
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 389.552 847.626 42.539 285.244 503.177
Other Current Liabilities, Total 270.535 348.684 190.728 249.183 189.849
Total Liabilities 2821.12 3050.4 3071.78 2699.02 3113.36
Total Long Term Debt 1471.9 1094.14 1880.21 1421.11 1671.09
Long Term Debt 1471.9 1094.14 1880.21 1421.11 1671.09
Deferred Income Tax 17.5 37.591 39.216 23.442 63.411
Minority Interest
Other Liabilities, Total 357.203 401.199 580.179 303.13 406.672
Total Equity 3466.61 3096.55 2797.84 2536.59 2634.97
Common Stock 2.702 2.702 2.702 2.702 2.702
Additional Paid-In Capital 1868.02 1818.51 1834.17 1777.02 1742.19
Retained Earnings (Accumulated Deficit) 2160.17 1791.74 1323.09 1178.46 1379.62
Treasury Stock - Common -160.188 -189.73 -118.301 -111.966 -178.903
Unrealized Gain (Loss) 0
Other Equity, Total -404.091 -326.67 -243.822 -309.619 -310.644
Total Liabilities & Shareholders’ Equity 6287.73 6146.95 5869.62 5235.62 5748.33
Total Common Shares Outstanding 227.716 227.074 227.985 227.752 225.509
Long Term Investments 23.5 25.4 4.1 80.7 60.6
Note Receivable - Long Term
Cash & Equivalents 608.355 645.135 352.611
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 1962.39 2311.43 2251.32 2393.95 2755.51
Cash and Short Term Investments 1015.78 1331.9 1287.34 1418.27 1886.98
Cash & Equivalents 579.935 609.549 359.18 730.669 1271.6
Short Term Investments 435.843 722.352 928.161 687.597 615.387
Total Receivables, Net 326.69 327.899 329.544 333.518 323.175
Accounts Receivable - Trade, Net 326.69 327.899 329.544 333.518 323.175
Total Inventory 399.207 391.989 380.824 357.96 323.472
Prepaid Expenses 220.715 259.639 253.609 284.208 221.882
Total Assets 5906.7 6347.27 6278.95 6287.73 6516.62
Property/Plant/Equipment, Total - Net 706.02 706.84 691.055 662.17 590.983
Property/Plant/Equipment, Total - Gross 1252.48 1222.98 1165.14 1075.87
Accumulated Depreciation, Total -545.641 -531.924 -502.967 -484.887
Goodwill, Net 2434.47 2456.54 2454.08 2352.57 2299.26
Intangibles, Net 542.604 570.192 585.021 544.796 551.587
Long Term Investments 27.3 27.7 23.5 21
Other Long Term Assets, Total 261.217 274.97 269.778 310.748 298.273
Total Current Liabilities 524.371 978.45 890.244 974.523 1497.54
Accounts Payable 76.887 83.939 84.386 98.734 82.836
Accrued Expenses 346.876 325.962 341.615 417.237 487.562
Notes Payable/Short Term Debt 0 0 0 0
Current Port. of LT Debt/Capital Leases 100.608 500.149 393.243 389.552 866.04
Other Current Liabilities, Total 68.4 71 69 61.1
Total Liabilities 2213 2723.66 2717.78 2821.12 3188.86
Total Long Term Debt 1382.36 1387.94 1486.71 1471.9 1423.21
Long Term Debt 1382.36 1387.94 1486.71 1471.9 1423.21
Deferred Income Tax 17.5 9.387
Other Liabilities, Total 306.268 357.273 340.827 357.203 258.726
Total Equity 3693.7 3623.61 3561.18 3466.61 3327.76
Common Stock 2.702 2.702 2.702 2.702 2.702
Additional Paid-In Capital 1903.08 1890.02 1882.16 1868.02 1854.36
Retained Earnings (Accumulated Deficit) 2360.88 2283.06 2215.43 2160.17 2072.57
Treasury Stock - Common -134.277 -134.277 -142.855 -160.188 -160.943
Other Equity, Total -438.687 -417.902 -396.261 -404.091 -440.933
Total Liabilities & Shareholders’ Equity 5906.7 6347.27 6278.95 6287.73 6516.62
Total Common Shares Outstanding 228.182 228.182 228.035 227.716 227.7
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 423.211 512.599 359.188 -41.455 190.38
Cash From Operating Activities 715.264 639.001 457.806 330.843 359.496
Cash From Operating Activities 208.397 214.931 205.014 231.458 206.436
Deferred Taxes -9.603 -5.288 -6.706 -55.362 -23.272
Non-Cash Items 125.14 46.771 -27.423 240.526 81.111
Cash Taxes Paid 98.565 102.083 42.572 41.474 29.317
Cash Interest Paid 23.208 21.588 25.351 29.721 25.902
Changes in Working Capital -31.881 -130.012 -72.267 -44.324 -95.159
Cash From Investing Activities -726.763 -202.426 -443.281 -222.278 -211.356
Capital Expenditures -149.336 -206.534 -304.237 -274.884 -150.763
Other Investing Cash Flow Items, Total -577.427 4.108 -139.044 52.606 -60.593
Cash From Financing Activities -125.803 -150.366 -50.127 -639.08 360.408
Financing Cash Flow Items -17.373 -16.953 -23.451 -61.279 -8.019
Issuance (Retirement) of Stock, Net 0.121 -92.068 8.876 62.362 -27.867
Issuance (Retirement) of Debt, Net -108.551 -41.345 -35.552 -640.163 396.294
Foreign Exchange Effects -12.545 -3.677 4.196 0.826 -7.183
Net Change in Cash -149.847 282.532 -31.406 -529.689 501.365
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 85.035 423.211 334.367 251.973 155.312
Cash From Operating Activities 71.926 715.264 590.945 379.363 207.41
Cash From Operating Activities 52.061 208.397 153.725 103.408 52.998
Deferred Taxes -4.341 -9.603 -40.196 -3.95 0.615
Non-Cash Items 13.323 125.14 95.413 47.519 21.86
Changes in Working Capital -74.152 -31.881 47.636 -19.587 -23.375
Cash From Investing Activities -433.847 -726.763 -602.237 -557.789 -306.252
Capital Expenditures -38.409 -149.336 -102.745 -76.024 -38.415
Other Investing Cash Flow Items, Total -395.438 -577.427 -499.492 -481.765 -267.837
Cash From Financing Activities -9.828 -125.803 420.57 12.549 -10.658
Financing Cash Flow Items -9.903 -17.373 49.011 12.443 -10.687
Issuance (Retirement) of Stock, Net 0.075 0.121 0.107 0.106 0.029
Issuance (Retirement) of Debt, Net -108.551 371.452 0 0
Foreign Exchange Effects 0.26 -12.545 -18.197 -8.105 -0.501
Net Change in Cash -371.489 -149.847 391.081 -173.982 -110.001
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
MFS Investment Management Investment Advisor/Hedge Fund 8.7992 20078128 -102677 2023-06-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.722 8492990 141460 2023-06-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 3.0334 6921770 10881 2023-05-09 LOW
Amundi Asset Management, SAS Investment Advisor/Hedge Fund 1.9838 4526635 1663553 2023-06-30 LOW
Fidelity International Investment Advisor 1.9505 4450800 1412750 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.9066 4350561 -90657 2023-06-30 LOW
UBS Asset Management (Switzerland) Investment Advisor 1.8754 4279398 765282 2022-12-19 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 1.466 3345086 580634 2023-06-30 LOW
BlackRock Asset Management Deutschland AG Investment Advisor 1.4559 3322170 25311 2023-09-30 LOW
Deka Investment GmbH Investment Advisor/Hedge Fund 1.2493 2850742 388353 2023-06-30 LOW
Marshall Wace LLP Investment Advisor/Hedge Fund 1.163 2653783 522140 2023-06-30 HIGH
Schroder Investment Management Ltd. (SIM) Investment Advisor/Hedge Fund 1.1065 2524765 -14911 2023-08-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.9641 2200010 -25442 2023-06-30 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.9014 2056848 327955 2023-06-30 LOW
Millennium Management LLC Hedge Fund 0.857 1955605 1619566 2023-06-30 HIGH
Morgan Stanley & Co. LLC Research Firm 0.8515 1943006 -12785 2023-06-30 MED
BofA Global Research (US) Research Firm 0.8364 1908531 -182510 2023-06-30 LOW
HSBC Global Asset Management (UK) Limited Investment Advisor/Hedge Fund 0.8349 1905156 -72184 2023-06-30 LOW
PRIMECAP Management Company Investment Advisor 0.8182 1867017 -3540 2023-06-30
Nekton Capital Limited Hedge Fund 0.7597 1733397 -49500 2023-06-30 HIGH

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Qiagen Company profile

About Qiagen NV

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Qiagen NV revenues increased 20% to $2.25B. Net income increased 43% to $512.6M. Revenues reflect Consumables and Related Revenues segment increase of 23% to $1.99B, Instrumentation segment increase of 4% to $265.3M, United States segment increase of 25% to $909.7M, Europe & Middle East & Afric segment increase of 19% to $814.4M. Net income benefited from Restructuring decrease of 81% to $27.8M (expense).

Equity composition

1/2017, Shares Consolidation (Factor: 0.96296).

Industry: Biotechnology & Medical Research (NEC)

Hulsterweg 82
VENLO
LIMBURG 5912 PL
NL

Income Statement

  • Annual
  • Quarterly

News

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023
GBP

UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

10:48, 21 November 2023

People also watch

XRP/USD

0.63 Price
-0.350% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

US100

16,001.20 Price
+0.470% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 7.0

Gold

2,072.25 Price
+1.760% 1D Chg, %
Long position overnight fee -0.0193%
Short position overnight fee 0.0111%
Overnight fee time 22:00 (UTC)
Spread 0.30

Oil - Crude

74.50 Price
-1.560% 1D Chg, %
Long position overnight fee -0.0136%
Short position overnight fee -0.0083%
Overnight fee time 22:00 (UTC)
Spread 0.040

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading